{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:53:19Z","timestamp":1781632399368,"version":"3.54.5"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T00:00:00Z","timestamp":1769212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":24,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Leprosy can vary in clinical forms, resulting in dermatoneurological disease with physical disabilities and leprosy reactions. This reaction involves complex immune system activity that can be influenced by vitamin D activity. The objective of this study was to evaluate the presence of autoantibodies in leprosy patients in Marab\u00e1, associating it with sociodemographic aspects and vitamin D levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>Cross-sectional study with leprosy patients treated at a Family Health Unit. Surveys of autoantibodies, vitamin D, and sociodemographic aspects were conducted.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Most patients were male (63.4%), aged equal or over 15 years old (80.5%), brown (68.3%), incomplete elementary education (41.5%) and earning between US$203.88 and US$407.76. The presence of autoantibodies was identified, with the most prevalent being anti-\u03b22-GPI IgM and ANA (AC-2, AC-4, and AC-20), both in 14.6% of participants, with statistical significance in the positivity of anti-\u03b22-GPI IgM in multibacillary patients. The average vitamin D level was 29.3 ng\/mL, with 43.8 ng\/mL for tuberculoid, 28.5 ng\/mL for borderline, and 24.9 ng\/mL for lepromatous.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our study demonstrated the presence of autoantibodies in leprosy patients in Marab\u00e1, more frequently in the lepromatous clinical form, and low levels of vitamin D in reactional states.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-026-12578-2","type":"journal-article","created":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T12:05:37Z","timestamp":1769256337000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Autoantibodies and vitamin D in leprosy patients in the Brazilian Amazon"],"prefix":"10.1186","volume":"26","author":[{"given":"Glaucielen Gomes","family":"da Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tinara Leila","family":"de Souza Aar\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas Corr\u00eaa","family":"Modesto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Arthur Moreira","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo Rodrigues Nunes","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael Malcher Meira","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz F\u00e1bio Magno","family":"Falc\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juarez Ant\u00f4nio Sim\u00f5es","family":"Quaresma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,24]]},"reference":[{"key":"12578_CR1","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/J.ABD.2021.08.006","volume":"97","author":"LAR Froes","year":"2022","unstructured":"Froes LAR, Sotto MN, Trindade MAB. Leprosy: clinical and immunopathological characteristics. Bras Dermatol. 2022;97:338. https:\/\/doi.org\/10.1016\/J.ABD.2021.08.006.","journal-title":"Bras Dermatol"},{"key":"12578_CR2","doi-asserted-by":"publisher","first-page":"918009","DOI":"10.3389\/FMICB.2022.918009","volume":"13","author":"N Cabral","year":"2022","unstructured":"Cabral N, de Figueiredo V, Gandini M, de Souza CF, Medeiros RA, Lery LMS, et al. Modulation of the response to Mycobacterium leprae and pathogenesis of leprosy. Front Microbiol. 2022;13:918009. https:\/\/doi.org\/10.3389\/FMICB.2022.918009.","journal-title":"Front Microbiol"},{"key":"12578_CR3","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1001\/jamadermatol.2020.0653","volume":"156","author":"CSS Teixeira","year":"2020","unstructured":"Teixeira CSS, Pescarini JM, Alves FJO, Nery JS, Sanchez MN, Teles C, et al. Incidence of and factors associated with leprosy among household contacts of patients with leprosy in Brazil. JAMA Dermatol. 2020;156:640\u20138. https:\/\/doi.org\/10.1001\/jamadermatol.2020.0653.","journal-title":"JAMA Dermatol"},{"key":"12578_CR4","unstructured":"Bhandari JAMRB, Awais M, Robbins BA, Gupta V, Leprosy. StatPearls [Internet] 2022. Available at: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK559307\/."},{"key":"12578_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2020.00567","volume":"11","author":"Z Mi","year":"2020","unstructured":"Mi Z, Liu H, Zhang F. Advances in the immunology and genetics of leprosy. Front Immunol. 2020;11:1\u201315. https:\/\/doi.org\/10.3389\/fimmu.2020.00567.","journal-title":"Front Immunol"},{"key":"12578_CR6","doi-asserted-by":"publisher","unstructured":"Sadhu S, Mitra DK. Emerging concepts of adaptive immunity in leprosy. Front Immunol. 2018;9. https:\/\/doi.org\/10.3389\/fimmu.2018.00604.","DOI":"10.3389\/fimmu.2018.00604"},{"key":"12578_CR7","unstructured":"da Brasil M. S (BR). Guide to leprosy control. Leprosy Control; 2002."},{"key":"12578_CR8","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jaad.2019.10.138","volume":"83","author":"MBC Maymone","year":"2020","unstructured":"Maymone MBC, Venkatesh S, Laughter M, Abdat R, Hugh J, Dacso MM, et al. Leprosy: treatment and management of complications. J Am Acad Dermatol. 2020;83:17\u201330. https:\/\/doi.org\/10.1016\/j.jaad.2019.10.138.","journal-title":"J Am Acad Dermatol"},{"key":"12578_CR9","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1097\/RHU.0000000000000379","volume":"22","author":"H El- Gendy","year":"2016","unstructured":"El- Gendy H, El- Gohary RM, Shohdy KS, Ragab G. Leprosy masquerading as systemic rheumatic diseases. JCR: J Clin Rheumatology. 2016;22:264\u201371. https:\/\/doi.org\/10.1097\/RHU.0000000000000379.","journal-title":"JCR: J Clin Rheumatology"},{"key":"12578_CR10","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.clindermatol.2015.10.006","volume":"34","author":"B Naafs","year":"2016","unstructured":"Naafs B, van Hees CLM. Leprosy type 1 reaction (formerly reversal reaction). Clin Dermatol. 2016;34:37\u201350. https:\/\/doi.org\/10.1016\/j.clindermatol.2015.10.006.","journal-title":"Clin Dermatol"},{"key":"12578_CR11","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.clindermatol.2014.07.002","volume":"33","author":"C Talhari","year":"2015","unstructured":"Talhari C, Talhari S, Penna GO. Clinical aspects of leprosy. Clin Dermatol. 2015;33:26\u201337. https:\/\/doi.org\/10.1016\/j.clindermatol.2014.07.002.","journal-title":"Clin Dermatol"},{"key":"12578_CR12","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1093\/rheumatology\/key125","volume":"57","author":"M Pawar","year":"2018","unstructured":"Pawar M, Zawar V. Mid -borderline leprosy masquerading as an overlap syndrome. Rheumatology. 2018;57:1686\u20138. https:\/\/doi.org\/10.1093\/rheumatology\/key125.","journal-title":"Rheumatology"},{"key":"12578_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-67361500678-9","author":"G Zhang","year":"2015","unstructured":"Zhang G, Jin H, Chen H, Lu Q. Cutaneous nodules with positive autoantibodies: histoid leprosy. Lancet. 2015;386:1915\u20136. https:\/\/doi.org\/10.1016\/S0140-67361500678-9.\u00a0"},{"key":"12578_CR14","first-page":"547","volume":"49","author":"SLE Ribeiro","year":"2009","unstructured":"Ribeiro SLE, Pereira HLA, Silva NP, Sato EI. Autoantibodies in patients with leprosy, with and without joint involvement, in the state of Amazonas. Rev Bras Rheumatol. 2009;49:547\u201361. http:\/\/www.scielo.br\/pdf\/rbr\/v49n5\/v49n5a06.pdf.","journal-title":"Rev Bras Rheumatol"},{"key":"12578_CR15","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s40249-017-0294-2","volume":"6","author":"CNC Bichara","year":"2017","unstructured":"Bichara CNC, Bichara CDA, Tostes C, Povoa MM, Quaresma JAS, Xavier MB. Prevalence of autoantibodies against cellular antigens in patients with HIV and leprosy coinfection in the Amazon region multilingual abstracts. Infect Dis Poverty. 2017;6:80. https:\/\/doi.org\/10.1186\/s40249-017-0294-2.","journal-title":"Infect Dis Poverty"},{"key":"12578_CR16","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.jped.2014.01.007","volume":"90","author":"L Neder","year":"2014","unstructured":"Neder L, Rondon DA, Cury SS, Da Silva CA. Musculoskeletal manifestations and autoantibodies in children and teenagers with leprosy. J Pediatr (Rio J). 2014;90:457\u201363. https:\/\/doi.org\/10.1016\/j.jped.2014.01.007.","journal-title":"J Pediatr (Rio J)"},{"key":"12578_CR17","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s12016-011-8294-7","volume":"42","author":"MF Cusick","year":"2012","unstructured":"Cusick MF, Libbey JE, Fujinami RS. Molecular mimicry as a mechanism of autoimmune disease. Clin Rev Allergy Immunol. 2012;42:102\u201311. https:\/\/doi.org\/10.1007\/s12016-011-8294-7.","journal-title":"Clin Rev Allergy Immunol"},{"key":"12578_CR18","doi-asserted-by":"publisher","unstructured":"Ao T, Kikuta J, Ishii M. The effects of vitamin D on immune system and inflammatory diseases. Biomolecules. 2021;11. https:\/\/doi.org\/10.3390\/biom11111624.","DOI":"10.3390\/biom11111624"},{"key":"12578_CR19","doi-asserted-by":"publisher","unstructured":"White JH. Emerging roles of vitamin D- induced antimicrobial peptides in antiviral innate immunity. Nutrients. 2022;14. https:\/\/doi.org\/10.3390\/nu14020284.","DOI":"10.3390\/nu14020284"},{"key":"12578_CR20","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1080\/15548627.2019.1569298","volume":"15","author":"LM Das","year":"2019","unstructured":"Das LM, Binko AM, Traylor ZP, Peng H, Lu KQ. Vitamin D improves sunburns by increasing autophagy in M2 macrophages. Autophagy. 2019;15:813\u201326. https:\/\/doi.org\/10.1080\/15548627.2019.1569298.","journal-title":"Autophagy"},{"key":"12578_CR21","doi-asserted-by":"publisher","first-page":"881","DOI":"10.2310\/JIM.0b013e31821b8755","volume":"59","author":"C Aranow","year":"2011","unstructured":"Aranow C. Vitamin D and the immune system. J Investig Med. 2011;59:881\u20136. https:\/\/doi.org\/10.231\/JIM.0b013e31821b8755.","journal-title":"J Investig Med"},{"key":"12578_CR22","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.humimm.2015.04.002","volume":"76","author":"VSK Neela","year":"2015","unstructured":"Neela VSK, Suryadevara NC, Shinde VG, Pydi SS, Jain S, Jonnalagada S, et al. Association of Taq I, Fok I and apa I polymorphisms in vitamin D receptor (VDR) gene with leprosy. Hum Immunol. 2015;76:402\u20135. https:\/\/doi.org\/10.1016\/j.humimm.2015.04.002.","journal-title":"Hum Immunol"},{"key":"12578_CR23","doi-asserted-by":"publisher","first-page":"e0006823","DOI":"10.1371\/journal.pntd.0006823","volume":"12","author":"I Singh","year":"2018","unstructured":"Singh I, Lavania M, Pathak VK, Ahuja M, Turankar RP, Singh V, et al. VDR polymorphism, gene expression and vitamin D levels in leprosy patients from North Indian population. PLoS Negl Trop Dis. 2018;12:e0006823. https:\/\/doi.org\/10.1371\/journal.pntd.0006823.","journal-title":"PLoS Negl Trop Dis"},{"key":"12578_CR24","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.jdermsci.2017.12.007","volume":"89","author":"TG Ara\u00fajo","year":"2018","unstructured":"Ara\u00fajo TG, Oliveira GP, de Matos Oliveira F, Neves AF, Soares Mota ST, Goulart IMB, et al. A novel vitamin D receptor polymorphism associated with leprosy. J Dermatol Sci. 2018;89:304\u20137. https:\/\/doi.org\/10.1016\/j.jdermsci.2017.12.007.","journal-title":"J Dermatol Sci"},{"key":"12578_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BSR20204102","volume":"41","author":"JL Pinto Paz","year":"2021","unstructured":"Pinto Paz JL, do Perp\u00e9tuo Socorro Corr\u00eaa Amador Silvestre M, Moura LS, Furlaneto IP, Rodrigues YC, Batista Lima KV, et al. Association of the polymorphism of the vitamin D receptor gene (VDR) with the risk of leprosy in the Brazilian Amazon. Biosci Rep. 2021;41:1\u20139. https:\/\/doi.org\/10.1042\/BSR20204102.","journal-title":"Biosci Rep"},{"key":"12578_CR26","doi-asserted-by":"publisher","unstructured":"Pepineli AC, Alves HV, Tiyo BT, Macedo LC, Visentainer L, de Lima Neto QA, et al. Vitamin D receptor gene polymorphisms are associated with leprosy in Southern Brazil. Front Immunol. 2019;10. https:\/\/doi.org\/10.3389\/fimmu.2019.02157.","DOI":"10.3389\/fimmu.2019.02157"},{"key":"12578_CR27","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1097\/MAJ.0b013e318232a6cf","volume":"343","author":"KVQ Luong","year":"2012","unstructured":"Luong KVQ, Nguyen LTH. Role of the vitamin D in leprosy. American journal of themedical. Sciences. 2012;343:471\u201382. https:\/\/doi.org\/10.1097\/MAJ.0b013e318232a6cf.","journal-title":"Sciences"},{"key":"12578_CR28","doi-asserted-by":"publisher","first-page":"104981","DOI":"10.1016\/j.micinf.2022.104981","volume":"24","author":"AL Grossi de Oliveira","year":"2022","unstructured":"Grossi de Oliveira AL, Chaves AT, Cardoso MS, Pinheiro GRG, Antunes DE, de Grossi MA. Reduced vitamin D receptor (VDR) and Cathelicidin antimicrobial peptide (CAMP) gene expression contribute i\u2019m the maintenance of inflammatory immune response in leprosy patients. Microbes Infect. 2022;24:104981. https:\/\/doi.org\/10.1016\/j.micinf.2022.104981.","journal-title":"Microbes Infect"},{"key":"12578_CR29","doi-asserted-by":"publisher","first-page":"104373","DOI":"10.1016\/j.micpath.2020.104373","volume":"147","author":"AL Grossi de Oliveira","year":"2020","unstructured":"Grossi de Oliveira AL, Chaves AT, Santos Cardoso M, Gomide Pinheiro GR, Parreiras de Jesus AC, de Faria Grossi MA, et al. Hypovitaminosis D and reduced Cathelicidin are strongly correlated during the multidrug therapy against leprosy. Microb Pathog. 2020;147:104373. https:\/\/doi.org\/10.1016\/j.micpath.2020.104373.","journal-title":"Microb Pathog"},{"key":"12578_CR30","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.nmni.2015.04.001","volume":"6","author":"D Mandal","year":"2015","unstructured":"Mandal D, Reja AHH, Biswas N, Bhattacharyya P, Patra PK, Bhattacharya B. Vitamin D receptor expression levels determine the severity and complexity of illness progression among leprosy reaction patients. New Microbes New Infect. 2015;6:35\u20139. https:\/\/doi.org\/10.1016\/j.nmni.2015.04.001.","journal-title":"New Microbes New Infect"},{"key":"12578_CR31","unstructured":"Pinheiro BV. da S. Spatial distribution of leprosy and its relationship with socioeconomic variables and public policies, in three municipalities in the state of Par\u00e1. Dissertation (Master\u2019s Degree in Health, Environment and Society in the Amazon) - Institute of Health Sciences, University Federal Do Par\u00e1 2017."},{"key":"12578_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1590\/0037-8682-0515-2020","volume":"53","author":"PML Neto","year":"2020","unstructured":"Neto PML, da Silva AR, Santos LH, Dos, Lima RJCP, Tauil PL. Gon\u00e7alves E Da G do R. Leprosy in children under 15 years of age in a municipality in Northeastern brazil: evolutionary aspects from 2003 to 2015. Rev Social Bras Med Trop. 2020;53:1\u20135. https:\/\/doi.org\/10.1590\/0037-8682-0515-2020.","journal-title":"Rev Social Bras Med Trop"},{"key":"12578_CR33","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1590\/S0034-71672007000600014","volume":"60","author":"FCF Lana","year":"2007","unstructured":"Lana FCF, Amaral EP, Lanza FM, Lima PL, Carvalho ACN, Diniz LG. Leprosy in children under 15 years of age in Vale do Jequitinhonha, Minas Gerais, Brazil. Rev Bras Enferm. 2007;60:696\u2013700. https:\/\/doi.org\/10.1590\/S0034-71672007000600014.","journal-title":"Rev Bras Enferm"},{"key":"12578_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pntd.0006788","volume":"12","author":"MCA Vieira","year":"2018","unstructured":"Vieira MCA, Nery JS, Paix\u00e3o ES, Freitas de Andrade KV, Oliveira Penna G, Teixeira MG. Leprosy in children under 15 years of age in brazil: A systematic review of the literature. PLoS Negl Trop Dis. 2018;12:1\u201313. https:\/\/doi.org\/10.1371\/journal.pntd.0006788.","journal-title":"PLoS Negl Trop Dis"},{"key":"12578_CR35","doi-asserted-by":"publisher","unstructured":"Pereira WMM, Braga RL, da Silva ER, dos Santos JNG, Vinente Neto BF, Mota JVF, et al. Leprosy and migration: Spatial correlation in a hyperendemic state in the Brazilian Amazon. Res Soc Dev. 2021;10:e1810111164. https:\/\/doi.org\/10.33448\/rsd-v10i1.11164.","DOI":"10.33448\/rsd-v10i1.11164"},{"key":"12578_CR36","doi-asserted-by":"crossref","unstructured":"Silva RDX, Ignotti E, Souza-Santos R, de Hacon S. S. Leprosy, social conditions and deforestation in the Brazilian Amazon. Rev Panam Salud Publica. 2010;27:268 \u2013\u200975. Available at: http:\/\/www.scielosp.org\/scielo.php?script=sci_arttext&pid=S1020-49892010000400005.","DOI":"10.1590\/S1020-49892010000400005"},{"key":"12578_CR37","doi-asserted-by":"publisher","first-page":"e10094","DOI":"10.22481\/rg.v6.e2022.e10094","volume":"6","author":"S de Silva","year":"2022","unstructured":"de Silva S. Production of urban space in Marab\u00e1 (PA): trajectories and processes. Geopauta. 2022;6:e10094. https:\/\/doi.org\/10.22481\/rg.v6.e2022.e10094.","journal-title":"Geopauta"},{"key":"12578_CR38","doi-asserted-by":"publisher","unstructured":"Rodrigues RN, Leano HA, de Bueno M, de C I, Ara\u00fajo KM da, Lana FA. FCF. High- risk areas of leprosy in Brazil between 2001\u20132015. Rev Bras Enferm 2020;73. https:\/\/doi.org\/10.1590\/0034-7167-2018-0583","DOI":"10.1590\/0034-7167-2018-0583"},{"key":"12578_CR39","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1590\/S0074-02762012000900011","volume":"107","author":"JG Barreto","year":"2012","unstructured":"Barreto JG, Guimar\u00e3es L, de Frade S, Rosa MAC, Salgado PS. High rates of undiagnosed leprosy and subclinical infection amongst school children in the Amazon region. Mem Inst Oswaldo Cruz. 2012;107:60\u20137. https:\/\/doi.org\/10.1590\/S0074-02762012000900011.","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"12578_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.abd.2022.08.009","author":"PC de Moraes","year":"2023","unstructured":"de Moraes PC, Eidt LM, Koehler A, Ransan LG, Scrofeneker ML. Epidemiological characteristics of leprosy from 2000 to 2019 in a state with low endemicity in Southern Brazil. Bras Dermatol. 2023. https:\/\/doi.org\/10.1016\/j.abd.2022.08.009.","journal-title":"Bras Dermatol"},{"key":"12578_CR41","doi-asserted-by":"publisher","unstructured":"Machado LMG, dos Santos ES, Cavaliero A, Steinmann P, Ignotti E. Spatio -temporal analysis of leprosy risks in a municipality in the state of Mato Grosso- Brazilian amazon: results from the post- exposure leprosy prophylaxis program in Brazil. Infect Dis Poverty. 2022;11. https:\/\/doi.org\/10.1186\/s40249-022-00943-7.","DOI":"10.1186\/s40249-022-00943-7"},{"key":"12578_CR42","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.4269\/ajtmh.14-0049","volume":"92","author":"RS Moura","year":"2015","unstructured":"Moura RS, Penna GO, Vaz Cardoso LP, De Andrade Pontes MA, Cruz R, De S\u00e1 Gon\u00e7alves H, et al. Description of leprosy classification at baseline among patients enrolled at the uniform multidrug therapy clinical trial for leprosy patients in Brazil. Am J Trop Med Hyg. 2015;92:1280\u20134. https:\/\/doi.org\/10.4269\/ajtmh.14-0049.","journal-title":"Am J Trop Med Hyg"},{"key":"12578_CR43","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.abd.2021.01.007","volume":"97","author":"DSe Silva","year":"2022","unstructured":"Silva DSe, Palheta J\u00fanior JIL, Pedrosa VL, Talhari C. Leprosy in the state of amazonas: is there actually a decrease in its incidence and prevalence ? Bras Dermatol. 2022;97:513\u20135. https:\/\/doi.org\/10.1016\/j.abd.2021.01.007.","journal-title":"Bras Dermatol"},{"key":"12578_CR44","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1093\/ije\/dyl072","volume":"35","author":"LRS Kerr-Pontes","year":"2006","unstructured":"Kerr-Pontes LRS, Barreto ML, Evangelista CMN, Rodrigues LC, Heukelbach J, Feldmeier H. Socioeconomic, environmental, and behavioral risk factors for leprosy in North- East Brazil: results of a case- control study. Int J Epidemiol. 2006;35:994\u20131000. https:\/\/doi.org\/10.1093\/ije\/dyl072.","journal-title":"Int J Epidemiol"},{"key":"12578_CR45","doi-asserted-by":"publisher","first-page":"e1226","DOI":"10.1016\/S2214-109X(19)30260-8","volume":"7","author":"JS Nery","year":"2019","unstructured":"Nery JS, Ramond A, Pescarini JM, Alves A, Strina A, Ichihara MY, et al. Socioeconomic determinants of leprosy new case detection in the 100 million Brazilian cohort: a population-based linking study. Lancet Glob Health. 2019;7:e1226\u201336. https:\/\/doi.org\/10.1016\/S2214-109X(19)30260-8.","journal-title":"Lancet Glob Health"},{"key":"12578_CR46","doi-asserted-by":"publisher","first-page":"7230","DOI":"10.1016\/j.vaccine.2021.10.027","volume":"39","author":"A van Hooij","year":"2021","unstructured":"van Hooij A, van den Eeden SJF, Khatun M, Soren S, Franken KLMC, Chandra Roy J, et al. BCG- induced immunity profiles in households contacts of leprosy patients differentiate between protection and disease. Vaccine. 2021;39:7230\u20137. https:\/\/doi.org\/10.1016\/j.vaccine.2021.10.027.","journal-title":"Vaccine"},{"key":"12578_CR47","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1590\/0037-8682-0245-2015","volume":"48","author":"S Araujo","year":"2015","unstructured":"Araujo S, Rezende MMF, de Sousa DCR, Rosa MR, dos Santos DC, Goulart LR, et al. Risk- benefit assessment of Bacillus Calmette-Gu\u00e9rin vaccination, anti-phenolic glycolipid I serology, and Mitsuda test response: 10-year follow-up of household contacts of leprosy patients. Rev Social Bras Med Trop. 2015;48:739\u201345. https:\/\/doi.org\/10.1590\/0037-8682-0245-2015.","journal-title":"Rev Social Bras Med Trop"},{"key":"12578_CR48","doi-asserted-by":"publisher","first-page":"6510","DOI":"10.1016\/j.vaccine.2019.08.067","volume":"37","author":"RR Gomes","year":"2019","unstructured":"Gomes RR, Antunes DE, dos Santos DF, Sabino EFP, Oliveira DB, Goulart IMB. BCG vaccine and leprosy household contacts: protective effect and probability i\u2019m becoming sick during follow-up. Vaccine. 2019;37:6510\u20137. https:\/\/doi.org\/10.1016\/j.vaccine.2019.08.067.","journal-title":"Vaccine"},{"key":"12578_CR49","doi-asserted-by":"publisher","unstructured":"Cuevas NC, Cardenas VM. Bacillus of calmette and Guerin (BCG) and the risk of leprosy in Ciudad Del Este, Paraguay, 2016\u20132017. Epidemiol Health 2021;43. https:\/\/doi.org\/10.4178\/epih.e2021060.","DOI":"10.4178\/epih.e2021060"},{"key":"12578_CR50","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1080\/21645515.2019.1706930","volume":"16","author":"MA Yamazaki-Nakashimada","year":"2020","unstructured":"Yamazaki-Nakashimada MA, Unzueta A, Berenise G\u00e1mez -Gonz\u00e1lez L, Gonz\u00e1lez- Salda\u00f1a N, Sorensen RU. BCG: a vaccine with multiple faces. Hum Vaccine Immunother. 2020;16:1841\u201350. https:\/\/doi.org\/10.1080\/21645515.2019.1706930.","journal-title":"Hum Vaccine Immunother"},{"key":"12578_CR51","unstructured":"BRASIL M da S. Leprosy Epidemiological Bulletin 2023."},{"key":"12578_CR52","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1111\/1756-185X.12668","volume":"19","author":"CF Dionello","year":"2016","unstructured":"Dionello CF, Rosa Utiyama SR, Radominski SC, Stahlke E, Stinghen ST, de Messias- Reason IJ. Evaluation of rheumatoid factor and anti-citrullinated peptide antibodies in relation i\u2019m rheumatological manifestations in patients with leprosy from Southern Brazil. Int J Rheum Dis. 2016;19:1024\u201331. https:\/\/doi.org\/10.1111\/1756-185X.12668.","journal-title":"Int J Rheum Dis"},{"key":"12578_CR53","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1590\/s0100-879x2008001100010","volume":"41","author":"SLE Ribeiro","year":"2008","unstructured":"Ribeiro SLE, Pereira HLA, Silva NP, Neves RMS, Sato EI. Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in leprosy patients with articular involvement. Braz J Med Biol Res. 2008;41:1005\u201310. https:\/\/doi.org\/10.1590\/s0100-879x2008001100010.","journal-title":"Braz J Med Biol Res"},{"key":"12578_CR54","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1177\/0961203314529469","volume":"23","author":"SLE Ribeiro","year":"2014","unstructured":"Ribeiro SLE, Pereira HLA, Silva NP, Sato EI, Passos LFS, Dos-Santos MC. Long-term persistence of anti -\u03b22 glycoprotein i in treated leprosy patients. Lupus. 2014;23:1249\u201351. https:\/\/doi.org\/10.1177\/0961203314529469.","journal-title":"Lupus"},{"key":"12578_CR55","first-page":"30","volume":"36","author":"SLE Ribeiro","year":"2011","unstructured":"Ribeiro SLE, Pereira HLA, Silva NP, Souza AWS, Sato EI. Anti-b2-glycoprotein i antibodies are highly prevalent in a large number of Brazilian leprosy patients. Acta Reumatol Port. 2011;36:30\u20137.","journal-title":"Acta Reumatol Port"},{"key":"12578_CR56","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1136\/ard.62.11.1106","volume":"62","author":"S Loizou","year":"2003","unstructured":"Loizou S, Singh S, Wypkema E, Asherson RA. Anticardiolipin, anti-b 2-glycoprotein I and antiprothrombin antibodies in black South African patients with infectious disease. Ann Rheum Dis. 2003;62:1106\u201311. https:\/\/doi.org\/10.1136\/ard.62.11.1106.","journal-title":"Ann Rheum Dis"},{"key":"12578_CR57","doi-asserted-by":"publisher","unstructured":"Ribeiro SLE, Pereira HLA, Boechat AL, Silva NP, Sato EI, Das Gra\u00e7as Souza Cunha M, et al. Epidemiological, clinical and immune factors that influence the persistence of antiphospholipid antibodies in leprosy. Adv Rheumatol. 2019;59. https:\/\/doi.org\/10.1186\/s42358-019-0094-4.","DOI":"10.1186\/s42358-019-0094-4"},{"key":"12578_CR58","doi-asserted-by":"publisher","unstructured":"Yang X, Dong H, Kuang YQ, Yu XF, Long H, Zhang CY, et al. Long-term presence of autoantibodies in plasma of cured leprosy patients. Sci Rep. 2023;13. https:\/\/doi.org\/10.1038\/s41598-022-27256-x.","DOI":"10.1038\/s41598-022-27256-x"},{"key":"12578_CR59","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1111\/jth.13379","volume":"14","author":"H Kelchtermans","year":"2016","unstructured":"Kelchtermans H, Pelkmans L, de Laat B, Devreese KM. IgG\/ IgM antiphospholipid antibodies present in the classification criteria for the antiphospholipid syndrome: a critical review of their association with thrombosis. J Thromb Haemost. 2016;14:1530\u201348. https:\/\/doi.org\/10.1111\/jth.13379.","journal-title":"J Thromb Haemost"},{"key":"12578_CR60","doi-asserted-by":"publisher","unstructured":"Silva DS da, Teixeira LAC, Beghini DG, Ferreira AT da S, Pinho M de, PS Rosa BM, et al. Blood coagulation abnormalities in multibacillary leprosy patients. PLoS Negl Trop Dis. 2018;12. https:\/\/doi.org\/10.1371\/journal.pntd.0006214.","DOI":"10.1371\/journal.pntd.0006214"},{"key":"12578_CR61","doi-asserted-by":"publisher","unstructured":"Jones D, CA J, Joshi A, AS S, Kumar H. Deep vein thrombosis in lepromatous leprosy: a case report of secondary pediatric antiphospholipid syndrome. Cureus 2022. https:\/\/doi.org\/10.7759\/cureus.21361","DOI":"10.7759\/cureus.21361"},{"key":"12578_CR62","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s42358-019-0069-5","volume":"59","author":"W Cruvinel","year":"2019","unstructured":"Cruvinel W, de Andrade M, von M\u00fchlen LEC, Dellavance CA, Ximenes A, Bichara AC. V Brazilian consensus guidelines for detection of anti-cell autoantibodies on hep-2 cells. Adv Rheumatol. 2019;59:28. https:\/\/doi.org\/10.1186\/s42358-019-0069-5.","journal-title":"Adv Rheumatol"},{"key":"12578_CR63","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1136\/annrheumdis-2012-201485","volume":"71","author":"SLE Ribeiro","year":"2012","unstructured":"Ribeiro SLE, Pereira HLA, Mangueira CL, Ferreira CES, Rosseto E, Scheinberg M. The development of arthritis and antinuclear antibodies correlate with serum 25-hydroxyvitamin D levels in patients with leprosy. Ann Rheum Dis. 2012;71:2062\u20133. https:\/\/doi.org\/10.1136\/annrheumdis-2012-201485.","journal-title":"Ann Rheum Dis"},{"key":"12578_CR64","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1590\/S0104-42302007000500021","volume":"53","author":"A Dellavance","year":"2007","unstructured":"Dellavance A, Leser PG, Andrade LEC. Importance of the fluorescence pattern in the interpretation of the FAN test - The case of the dense fine dotted pattern. Rev Assoc Med Bras. 2007;53:439\u201345. https:\/\/doi.org\/10.1590\/S0104-42302007000500021.","journal-title":"Rev Assoc Med Bras"},{"key":"12578_CR65","doi-asserted-by":"publisher","unstructured":"Carter JB, Carter S, Saschenbrecker S, Goeckeritz BE. Recognition and relevance of Anti-DFS70 autoantibodies in routine antinuclear autoantibodies testing at a community hospital. Front Med (Lausanne). 2018;5. https:\/\/doi.org\/10.3389\/fmed.2018.00088.","DOI":"10.3389\/fmed.2018.00088"},{"key":"12578_CR66","doi-asserted-by":"publisher","first-page":"e101780","DOI":"10.1371\/journal.pone","volume":"9","author":"CPB Passaes","year":"2014","unstructured":"Passaes CPB, Cardoso CC, Caetano DG, Teixeira SLM, Guimar\u00e3es ML, Campos DP, et al. Association of single nucleotide polymorphisms in the lens Epithelium-Derived growth factor (LEDGF\/p75) with HIV-1 infection outcomes in Brazilian HIV-1\u2009+\u2009Individuals. PLoS ONE. 2014;9:e101780. https:\/\/doi.org\/10.1371\/journal.pone.","journal-title":"PLoS ONE"},{"key":"12578_CR67","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.1007\/s10067-019-04667-2","volume":"38","author":"SLE Ribeiro","year":"2019","unstructured":"Ribeiro SLE, Nunes GPS, de Freitas HEG, Mangueira C, Scheinberg MA. Negative specificity for DSF70 in ANA positive leprosy will be. Clin Rheumatol. 2019;38:2953\u20135. https:\/\/doi.org\/10.1007\/s10067-019-04667-2.","journal-title":"Clin Rheumatol"},{"key":"12578_CR68","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1007\/s12016-016-8564-5","volume":"52","author":"K Conrad","year":"2017","unstructured":"Conrad K, R\u00f6ber N, Andrade LEC, Mahler M. The clinical relevance of Anti-DFS70 autoantibodies. Clin Rev Allergy Immunol. 2017;52:202\u201316. https:\/\/doi.org\/10.1007\/s12016-016-8564-5.","journal-title":"Clin Rev Allergy Immunol"},{"key":"12578_CR69","doi-asserted-by":"publisher","unstructured":"Lundgren MC, Sapkota S, Peterson DJ, Crosson JT. The antinuclear antibody dense fine speckled pattern and possible clinical associations: an indication of a proinflammatory microenvironment. J Immunol Methods. 2021;488. https:\/\/doi.org\/10.1016\/j.jim.2020.112904.","DOI":"10.1016\/j.jim.2020.112904"},{"key":"12578_CR70","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1590\/abd1806-4841.20175423","volume":"92","author":"TCPC de Andrade","year":"2017","unstructured":"de Andrade TCPC, Vieira BC, Soares CT, Martins TY, Santiago TM, Barreto JA. Lepromatous leprosy simulation rheumatoid arthritis \u2013 Report of a neglected disease. Bras Dermatol. 2017;92:389\u201391. https:\/\/doi.org\/10.1590\/abd1806-4841.20175423.","journal-title":"Bras Dermatol"},{"key":"12578_CR71","doi-asserted-by":"publisher","first-page":"741","DOI":"10.2147\/IDR.S202386","volume":"12","author":"W Gao","year":"2019","unstructured":"Gao W, Chen Z, Jiang H, Shi Y, Zhang W, Wang H. Diffuse multibacillary leprosy patient with lucio\u2019s phenomenon and positive anticardiolipin antibody misdiagnosed as lupus erythematosus panniculitis in the people\u2019s Republic of China. Infect Drug Resist. 2019;12:741\u20134. https:\/\/doi.org\/10.2147\/IDR.S202386.","journal-title":"Infect Drug Resist"},{"key":"12578_CR72","doi-asserted-by":"publisher","first-page":"709","DOI":"10.3390\/biom13040709","volume":"13","author":"L Athanassiou","year":"2023","unstructured":"Athanassiou L, Kostoglou-Athanassiou I, Koutsilieris M, Shoenfeld Y. Vitamin D and autoimmune rheumatic diseases. Biomolecules. 2023;13:709. https:\/\/doi.org\/10.3390\/biom13040709.","journal-title":"Biomolecules"},{"key":"12578_CR73","doi-asserted-by":"publisher","unstructured":"Yamamoto EA, Nguyen JK, Liu J, Keller E, Campbell N, Zhang CJ, et al. Low levels of vitamin D promotes memory B cells in lupus. Nutrients. 2020;12. https:\/\/doi.org\/10.3390\/nu12020291.","DOI":"10.3390\/nu12020291"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-12578-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12578-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12578-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:05:56Z","timestamp":1781629556000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-12578-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,24]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12578"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-12578-2","relation":{"references":[{"id-type":"doi","id":"10.1016\/S0140-6736(15)00678-9","asserted-by":"subject"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,24]]},"assertion":[{"value":"17 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"As a result of this study involved patient data, it was submitted to the Research Ethics Committee of the Center for Tropical Medicine (NMT)\/Federal University of Par\u00e1 (UFPA) and the Research Ethics Committee of the State University of Par\u00e1, Campus VIII, and was approved under protocol numbers 3,966,220 and 3,851,670, respectively. We emphasize that the research project was designed for this study and that all data obtained in the research are presented in this study and have not been submitted elsewhere. All participants were invited to participate in the study after the objectives and methods were presented. After acceptance, participants signed an Free and Informed Consent Form. Participants under 18 years of age were included in the study only after obtaining written authorization from their parents or legal guardians, who signed the Consent Form for their minors\u2019 participation in the research, and after the Free and Informed Assent Form was filled. This study was conducted in accordance with the Declaration of Helsinki and guidelines for research involving human subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"384"}}